Breast Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Histologically or cytologically confirmed invasive breast cancer, TNM stage I–III. 2.Planned to receive, or currently receiving, AC regimen chemotherapy (doxorubicin/epirubicin plus cyclophosphamide) with a 21-day cycle; total planned cycles >= 4. Patients may be enrolled either before the first chemotherapy cycle or within 7 days after the first cycle. 3.Age 18–70 years, with Eastern Cooperative Oncology Group (ECOG) performance status 0–1. 4.Possession of a smartphone with basic operational skills and adequate cognitive function (Mini-Mental State Examination [MMSE] score >= 24). 5.Signed informed consent, willing to participate in the study, and committed to comply with follow-up.
Exclusion criteria
Exclusion criteria: 1.History of myocardial infarction, unstable angina, congestive heart failure, or serious arrhythmias, or resting electrocardiogram showing significant abnormalities. 2.Severe musculoskeletal disorders or confirmed bone metastases. 3.Baseline hematology showing neutrophil count = 20). 6.Participation in other exercise intervention studies or having performed systematic exercise training in the past 6 months (>=3 sessions per week,>=30 minutes per session). 7.Pregnant or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom Clusters Assessment;Hematological and Biochemical Parameters Assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Assessment;Physical Function;VILPA Adherence; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Hainan Medical University